Abstract
Infection of man and domestic animals with Brucei group African trypanosomes results in a fatal disease. The immunobiological events that underlie temporal host resistance and susceptibility during an infection are complex but informative, because the parasites activate and engage nearly every element of the host innate and adaptive immune system. The ability of trypanosomes to undergo extensive antigenic variation provides a means to escape adaptive immunity, but these protozoan pathogens also activate and regulate many elements of the host immune response to their own end. This chapter highlights the trypanosome elements that bridge innate and adaptive immune responses in the infected mammalian host: the pathogen-associated molecular patterns (PAMPs) that trigger the innate immune response; the associated pattern recognition receptors (PRRs) on innate immune cells and subcellular signaling events that are activated; the resulting pattern of pro-inflammatory gene expression that shapes the nascent adaptive immune response; and, the downstream elements that ultimately cause host resistance to fail. The chapter concludes with promising new approaches, informed by recent studies of immunological memory, aimed at protecting trypanosome infected hosts against a broad range of antigenic variants.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amit I, Garber M, Chevrier N, Leite A, Donner Y, Eisenhaure T, Guttman M, Grenier J, Li W, Zuk O, Schubert L, Birditt B, Shay T, Goren A, Zhang X, Smith Z, Deering R, McDonald R, Cabili M, Bernstein B, Rinn J, Meissner A, Root D, Hacohen N, Regev A (2009) Unbiased reconstruction of a mammalian transcriptional network mediating pathogen responses. Science 326(5950):257–263
Barkhuizen M, Magez S, Atkinson RA, Brombacher F (2007) Interleukin-12p70-dependent interferon- gamma production is crucial for resistance in African trypanosomiasis. J Infect Dis 196(8):1253–1260
Barkhuizen M, Magez S, Ryffel B, Brombacher F (2008) Interleukin-12p70 deficiency increases survival and diminishes pathology in Trypanosoma congolense infection. J Infect Dis 198(9):1284–1291
Barry JD, Turner CM (1991) The dynamics of antigenic variation and growth of African trypanosomes. Parasitol Today 7(8):207–211
Barry JD, Hall JP, Plenderleith L (2012) Genome hyperevolution and the success of a parasite. Ann N Y Acad Sci 1267:11–17
Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bartholomeu DC, Lennard NJ, Caler E, Hamlin NE, Haas B, Bohme U, Hannick L, Aslett MA, Shallom J, Marcello L, Hou L, Wickstead B, Alsmark UC, Arrowsmith C, Atkin RJ, Barron AJ, Bringaud F, Brooks K, Carrington M, Cherevach I, Chillingworth TJ, Churcher C, Clark LN, Corton CH, Cronin A, Davies RM, Doggett J, Djikeng A, Feldblyum T, Field MC, Fraser A, Goodhead I, Hance Z, Harper D, Harris BR, Hauser H, Hostetler J, Ivens A, Jagels K, Johnson D, Johnson J, Jones K, Kerhornou AX, Koo H, Larke N, Landfear S, Larkin C, Leech V, Line A, Lord A, Macleod A, Mooney PJ, Moule S, Martin DM, Morgan GW, Mungall K, Norbertczak H, Ormond D, Pai G, Peacock CS, Peterson J, Quail MA, Rabbinowitsch E, Rajandream MA, Reitter C, Salzberg SL, Sanders M, Schobel S, Sharp S, Simmonds M, Simpson AJ, Tallon L, Turner CM, Tait A, Tivey AR, Van Aken S, Walker D, Wanless D, Wang S, White B, White O, Whitehead S, Woodward J, Wortman J, Adams MD, Embley TM, Gull K, Ullu E, Barry JD, Fairlamb AH, Opperdoes F, Barrell BG, Donelson JE, Hall N, Fraser CM, Melville SE, El-Sayed NM (2005) The genome of the African trypanosome Trypanosoma brucei. Science 309(5733):416–422
Blum ML, Down JA, Gurnett AM, Carrington M, Turner MJ, Wiley DC (1993) A structural motif in the variant surface glycoproteins of Trypanosoma brucei. Nature 362(6421):603–609
Bockstal V, Geurts N, Magez S (2011a) Acute disruption of bone marrow B lymphopoiesis and apoptosis of transitional and marginal zone B cells in the spleen following a blood-stage Plasmodium chabaudi infection in mice. J Parasitol Res 2011:534697
Bockstal V, Guirnalda P, Caljon G, Goenka R, Telfer JC, Frenkel D, Radwanska M, Magez S, Black SJ (2011b) T. brucei infection reduces B lymphopoiesis in bone marrow and truncates compensatory splenic lymphopoiesis through transitional B-cell apoptosis. PLoS Pathog 7(6):e1002089
Bojarova P, Denehy E, Walker I, Loft K, De Souza DP, Woo LW, Potter BV, McConville MJ, Williams SJ (2008) Direct evidence for ArO-S bond cleavage upon inactivation of Pseudomonas aeruginosa arylsulfatase by aryl sulfamates. Chembiochem 9(4):613–623
Bowdish DM, Gordon S (2009) Conserved domains of the class A scavenger receptors: evolution and function. Immunol Rev 227(1):19–31
Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG (2009) MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5(6):e1000474
Carrington M, Miller N, Blum M, Roditi I, Wiley D, Turner M (1991a) Variant specific glycoprotein of Trypanosoma brucei consists of two domains each having an independently conserved pattern of cysteine residues. J Mol Biol 221:823–835
Carrington M, Walters D, Webb H (1991b) The biology of the glycosylphosphatidylinositol-specific phospholipase C of Trypanosoma brucei. Cell Biol Int Rep 15:1101–1114
Carrington M, Carnall N, Crow MS, Gaud A, Redpath MB, Wasunna CL, Webb H (1998) The properties and function of the glycosylphosphatidylinositol-phospholipase C in Trypanosoma brucei. Mol Biochem Parasitol 91(1):153–164
Chattopadhyay A, Jones NG, Nietlispach D, Nielsen PR, Voorheis HP, Mott HR, Carrington M (2005) Structure of the C-terminal domain from Trypanosoma brucei variant surface glycoprotein MITat1.2. J Biol Chem 280(8):7228–7235
Coller SP, Paulnock DM (2001) Signaling pathways initiated in macrophages after engagement of type A scavenger receptors. J Leukoc Biol 70(1):142–148
Coller SP, Mansfield JM, Paulnock DM (2003) Glycosylinositolphosphate soluble variant surface glycoprotein inhibits IFN-gamma-induced nitric oxide production via reduction in STAT1 phosphorylation in African trypanosomiasis. J Immunol 171(3):1466–1472
Cross GA (1975) Identification, purification and properties of clone-specific glycoprotein antigens constituting the surface coat of Trypanosoma brucei. Parasitology 71:393–417
Dagenais TR, Demick KP, Bangs JD, Forest KT, Paulnock DM, Mansfield JM (2009a) T-cell responses to the trypanosome variant surface glycoprotein are not limited to hypervariable subregions. Infect Immun 77(1):141–151
Dagenais TR, Freeman BE, Demick KP, Paulnock DM, Mansfield JM (2009b) Processing and presentation of variant surface glycoprotein molecules to T cells in African trypanosomiasis. J Immunol 183(5):3344–3355
De Gee AL, Sonnenfeld G, Mansfield JM (1985) Genetics of resistance to the African trypanosomes. V. Qualitative and quantitative differences in interferon production among susceptible and resistant mouse strains. J Immunol 134:2723–2726
De Gee AL, Levine RF, Mansfield JM (1988) Genetics of resistance to the African trypanosomes. VI. Heredity of resistance and variable surface glycoprotein-specific immune responses. J Immunol 140(1):283–288
DeGee AL, Mansfield JM (1984) Genetics of resistance to the African trypanosomes. IV. Resistance of radiation chimeras to Trypanosoma rhodesiense infection. Cell Immunol 87(1):85–91
Demick K, Paulnock DM, Mansfield JM (2013) Evaluation of extravascular parasite burden in infected animals by use of African trypanosomes constitutively and stably expressing a cytoplasmic eGFP+ marker (submitted for publication)
Dempsey WL, Mansfield JM (1983) Lymphocyte function in experimental African trypanosomiasis. V. Role of antibody and the mononuclear phagocyte system in variant-specific immunity. J Immunol 130(1):405–411
DeWitte-Orr SJ, Collins SE, Bauer CM, Bowdish DM, Mossman KL (2010) An accessory to the ‘Trinity’: SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog 6(3):e1000829
Drennan MB, Stijlemans B, Van den Abbeele J, Quesniaux VJ, Barkhuizen M, Brombacher F, De Baetselier P, Ryffel B, Magez S (2005) The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J Immunol 175(4):2501–2509
Field MC, Boothroyd JC (1996) Sequence divergence in a family of variant surface glycoprotein genes from trypanosomes: coding region hypervariability and downstream recombinogenic repeats. J Mol Evol 42(5):500–511
Field MC, Menon AK, Cross GA (1991) Developmental variation of glycosylphosphatidylinositol membrane anchors in Trypanosoma brucei. Identification of a candidate biosynthetic precursor of the glycosylphosphatidylinositol anchor of the major procyclic stage surface glycoprotein. J Biol Chem 266(13):8392–8400
Foulds KE, Wu CY, Seder RA (2006) Th1 memory: implications for vaccine development. Immunol Rev 211:58–66
Freeman B, Mansfield JM, Paulnock DM (2013) Altered antigen processing and presentation by dendritic cells in chronic African trypanosomiasis (in preparation)
Freymann D, Down J, Carrington M, Roditi I, Turner M, Wiley D (1990) 2.9 Å resolution structure of the N-terminal domain of a variant surface glycoprotein from Trypanosoma brucei. J Mol Biol 216:141–160
Gangloff M, Gay NJ (2008) Baseless assumptions: activation of TLR9 by DNA. Immunity 28(3):293–294
Hall JP, Wang H, Barry JD (2013) Mosaic VSGs and the scale of Trypanosoma brucei antigenic variation. PLoS Pathog (in press)
Hanrahan O, Webb H, O’Byrne R, Brabazon E, Treumann A, Sunter JD, Carrington M, Voorheis HP (2009) The glycosylphosphatidylinositol-PLC in Trypanosoma brucei forms a linear array on the exterior of the flagellar membrane before and after activation. PLoS Pathog 5(6):e1000468
Hansen JK, Demick KP, Mansfield JM, Forest KT (2007) Conserved regions from Neisseria gonorrhoeae pilin are immunosilent and not immunosuppressive. Infect Immun 75(8):4138–4147
Harris TH, Cooney NM, Mansfield JM, Paulnock DM (2006) Signal transduction, gene transcription, and cytokine production triggered in macrophages by exposure to trypanosome DNA. Infect Immun 74(8):4530–4537
Harris TH, Mansfield JM, Paulnock DM (2007) CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infect Immun 75(5):2366–2373
Hedberg G, Paulnock D, Mansfield J (2013) CD4+ Th memory cell responses to the variant surface glycoprotein during African trypanosomiasis (submitted for publication)
Hedberg G, Paulnock D, Mansfield J (2013) Induction of cross-variant protective immunity to the African trypanosomes following immunization with conserved C-terminal VSG sequences. (in preparation)
Hertz CJ, Filutowicz H, Mansfield JM (1998) Resistance to the African trypanosomes is IFN-gamma dependent. J Immunol 161(12):6775–6783
Inverso JA, Mansfield JM (1983) Genetics of resistance to the African trypanosomes. II. Differences in virulence associated with VSSA expression among clones of Trypanosoma rhodesiense. J Immunol 130(1):412–417
Kaushik RS, Uzonna JE, Zhang Y, Gordon JR, Tabel H (2000) Innate resistance to experimental African trypanosomiasis: differences in cytokine (TNF-alpha, IL-6, IL-10 and IL-12) production by bone marrow-derived macrophages from resistant and susceptible mice. Cytokine 12(7):1024–1034
Leppert BJ, Mansfield JM, Paulnock DM (2007) The soluble variant surface glycoprotein of African trypanosomes is recognized by a macrophage scavenger receptor and induces I kappa B alpha degradation independently of TRAF6-mediated TLR signaling. J Immunol 179(1):548–556
Levine RF, Mansfield JM (1981) Genetics of resistance to African trypanosomes: role of the H-2 locus in determining resistance to infection with Trypanosoma rhodesiense. Infect Immun 34(2):513–518
Levine RF, Mansfield JM (1984) Genetics of resistance to the African trypanosomes. III. Variant-specific antibody responses of H-2-compatible resistant and susceptible mice. J Immunol 133(3):1564–1569
Lopez R, Demick KP, Mansfield JM, Paulnock DM (2008) Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J Immunol 181(7):4908–4917
Lucas R, Magez S, De-Leys R, Fransen L, Scheerlinck JP, Rampelberg M, Sablon E, De-Baetselier P (1994) Mapping the lectin-like activity of tumor necrosis factor. Science 263(5148):814–817
MacLean L, Odiit M, Sternberg JM (2001) Nitric oxide and cytokine synthesis in human African trypanosomiasis. J Infect Dis 184(8):1086–1090
Magez S, Radwanska M (2009) African trypanosomiasis and antibodies: implications for vaccination, therapy and diagnosis. Future Microbiol 4:1075–1087
Magez S, Lucas R, Darji A, Songa EB, Hamers R, De Baetselier P (1993) Murine tumour necrosis factor plays a protective role during the initial phase of the experimental infection with Trypanosoma brucei brucei. Parasite Immunol 15(11):635–641
Magez S, Geuskens M, Beschin A, del Favero H, Verschueren H, Lucas R, Pays E, de Baetselier P (1997) Specific uptake of tumor necrosis factor-alpha is involved in growth control of Trypanosoma brucei. J Cell Biol 137(3):715–727
Magez S, Stijlemans B, Radwanska M, Pays E, Ferguson MA, De Baetselier P (1998) The glycosyl-inositol-phosphate and dimyristoylglycerol moieties of the glycosylphosphatidylinositol anchor of the trypanosome variant-specific surface glycoprotein are distinct macrophage-activating factors. J Immunol 160(4):1949–1956
Magez S, Stijlemans B, Baral T, De Baetselier P (2002) VSG-GPI anchors of African trypanosomes: their role in macrophage activation and induction of infection-associated immunopathology. Microbes Infect 4(9):999–1006
Mansfield JM, Olivier M (2010) Immune evasion by parasites. In: Kaufmann SHE, Sher A, Ahmed R, Sacks D (eds) Immunology of infectious diseases, vol 2. ASM, Washington, DC, pp 379–392
Mansfield JM, Paulnock DM (2005) Regulation of innate and acquired immunity in African trypanosomiasis. Parasite Immunol 27(10–11):361–371
Marcello L, Menon S, Ward P, Wilkes JM, Jones NG, Carrington M, Barry JD (2007) VSGdb: a database for trypanosome variant surface glycoproteins, a large and diverse family of coiled coil proteins. BMC Bioinformatics 8:143
Medvedev AE, Kopydlowski KM, Vogel SN (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164(11):5564–5574
Mensa Wilmot K, Hereld D, Englund PT (1990) Genomic organization, chromosomal localization, and developmentally regulated expression of the glycosyl-phosphatidylinositol-specific phospholipase C of Trypanosoma brucei. Mol Cell Biol 10:720–726
Metcalf P, Blum M, Freymann D, Turner M, Wiley DC (1987) Two variant surface glycoproteins of Trypanosoma brucei of different sequence classes have similar 6 A resolution X-ray structures. Nature 325:84–86
Namangala B, Brys L, Magez S, De Baetselier P, Beschin A (2000a) Trypanosoma brucei brucei infection impairs MHC class II antigen presentation capacity of macrophages. Parasite Immunol 22(7):361–370
Namangala B, de Baetselier P, Brijs L, Stijlemans B, Noel W, Pays E, Carrington M, Beschin A (2000b) Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines. J Infect Dis 181(3):1110–1120
Paulnock DM, Coller SP (2001) Analysis of macrophage activation in African trypanosomiasis. J Leukoc Biol 69(5):685–690
Paulnock DM, Smith C, Mansfield JM (1989) Antigen presenting cell function in African trypanosomiasis. Alan R Liss, New York, pp 135–144
Paulnock DM, Freeman BE, Mansfield JM (2010) Modulation of innate immunity by African trypanosomes. Parasitology 137(14):2051–2063
Radwanska M, Guirnalda P, De Trez C, Ryffel B, Black S, Magez S (2008) Trypanosomiasis-induced B cell apoptosis results in loss of protective anti-parasite antibody responses and abolishment of vaccine-induced memory responses. PLoS Pathog 4(5):e1000078
Reinitz DM, Aizenstein BD, Mansfield JM (1992) Variable and conserved structural elements of trypanosome variant surface glycoproteins. Mol Biochem Parasitol 51(1):119–132
Salmon D, Vanwalleghem G, Morias Y, Denoeud J, Krumbholz C, Lhomme F, Bachmaier S, Kador M, Gossmann J, Dias FB, De Muylder G, Uzureau P, Magez S, Moser M, De Baetselier P, Van Den Abbeele J, Beschin A, Boshart M, Pays E (2012) Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host. Science 337(6093):463–466
Schleifer KW, Mansfield JM (1993) Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J Immunol 151(10):5492–5503
Schleifer KW, Filutowicz H, Schopf LR, Mansfield JM (1993) Characterization of T helper cell responses to the trypanosome variant surface glycoprotein. J Immunol 150(7):2910–2919
Schopf LR, Filutowicz H, Bi XJ, Mansfield JM (1998) Interleukin-4-dependent immunoglobulin G1 isotype switch in the presence of a polarized antigen-specific Th1-cell response to the trypanosome variant surface glycoprotein. Infect Immun 66(2):451–461
Schwede A, Jones N, Engstler M, Carrington M (2011) The VSG C-terminal domain is inaccessible to antibodies on live trypanosomes. Mol Biochem Parasitol 175(2):201–204
Sprent J (1994) T and B memory cells. Cell 76(2):315–322
Sternberg JM, Rodgers J, Bradley B, Maclean L, Murray M, Kennedy PG (2005) Meningoencephalitic African trypanosomiasis: brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. J Neuroimmunol 167(1–2):81–89
Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, Khoury JE, Golenbock DT, Moore KJ (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11(2):155–161
Stijlemans B, Baral TN, Guilliams M, Brys L, Korf J, Drennan M, Van Den Abbeele J, De Baetselier P, Magez S (2007) A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis-associated immunopathology. J Immunol 179(6):4003–4014
Tachado SD, Gerold P, Schwarz R, Novakovic S, McConville M, Schofield L (1997) Signal transduction in macrophages by glycosylphosphatidylinositols of Plasmodium, Trypanosoma, and Leishmania: activation of protein tyrosine kinases and protein kinase C by inositolglycan and diacylglycerol moieties. Proc Natl Acad Sci USA 94(8):4022–4027
Todt JC, Hu B, Curtis JL (2008) The scavenger receptor SR-A I/II (CD204) signals via the receptor tyrosine kinase Mertk during apoptotic cell uptake by murine macrophages. J Leukoc Biol 84(2):510–518
Uzonna JE, Kaushik RS, Gordon JR, Tabel H (1999) Cytokines and antibody responses during Trypanosoma congolense infections in two inbred mouse strains that differ in resistance. Parasite Immunol 21(2):57–71
Van der Ploeg LH, Gottesdiener K, Lee MG (1992) Antigenic variation in African trypanosomes. Trends Genet 8:452–457
Vickerman K, Luckins AG (1969) Localization of variable antigens in the surface coat of Trypanosoma brucei using ferritin conjugated antibody. Nature 224:1125–1126
Vincendeau P, Daulouede S, Veyret B, Darde ML, Bouteille B, Lemesre JL (1992) Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Exp Parasitol 75:353–360
Webb H, Carnall N, Carrington M (1994) The role of GPI-PLC in Trypanosoma brucei. Braz J Med Biol Res 27(2):349–356
Webb H, Carnall N, Vanhamme L, Rolin S, Van Den Abbeele J, Welburn S, Pays E, Carrington M (1997a) The GPI-phospholipase C of Trypanosoma brucei is nonessential but influences parasitemia in mice. J Cell Biol 139(1):103–114
Webb H, Carnall N, Vanhamme L, Rolin S, Vandenabbeele J, Welburn S, Pays E, Carrington M (1997b) The Gpi-phospholipase C of Trypanosoma brucei is nonessential but influences parasitemia in mice. J Cell Biol 139(1):103–114
Yew KH, Carsten B, Harrison C (2010) Scavenger receptor A1 is required for sensing HCMV by endosomal TLR-3/-9 in monocytic THP-1 cells. Mol Immunol 47(4):883–893
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Wien
About this chapter
Cite this chapter
Mansfield, J.M., Paulnock, D.M., Hedberg, G.M. (2014). Bridging Innate and Adaptive Immunity in African Trypanosomiasis. In: Magez, S., Radwanska, M. (eds) Trypanosomes and Trypanosomiasis. Springer, Vienna. https://doi.org/10.1007/978-3-7091-1556-5_4
Download citation
DOI: https://doi.org/10.1007/978-3-7091-1556-5_4
Published:
Publisher Name: Springer, Vienna
Print ISBN: 978-3-7091-1555-8
Online ISBN: 978-3-7091-1556-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)